« Back to Medicines list

Jext 150mcg

  • Name:

    Jext 150mcg

  • Company:
    info
  • Active Ingredients:

    Adrenaline tartrate

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 19/12/18

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 15/6/2020

Click on this link to Download PDF directly

ALK-Abello Ltd

ALK-Abello Ltd

Company Products

Medicine NameActive Ingredients
Medicine Name ACARIZAX 12 SQ-HDM oral lyophilisate Active Ingredients Allergen extract from house dust mites
Medicine Name ALUTARD SQ Bee 100,000 SQ-U/ml Active Ingredients Allergen from honey bee venom
Medicine Name ALUTARD SQ Bee Initial pack (100 SQ-U/ml, 1,000 SQ-U/ml, 10,000 SQ-U/ml, 100,000 SQ-U/ml) Active Ingredients Allergen from honey bee venom
Medicine Name ALUTARD SQ Wasp 100,000 SQ-U/ml Active Ingredients Allergen from wasp venom
Medicine Name ALUTARD SQ Wasp Initial Pack (100 SQ-U/ml, 1,000 SQ-U/ml, 10,000 SQ-U/ml, 100,000 SQ-U/ml) Active Ingredients Allergen from wasp venom
Medicine Name GRAZAX 75,000 SQ-T oral lyophilisate Active Ingredients allergen extract of grass pollen from Timothy (Phleum pratense)
Medicine Name ITULAZAX 12 SQ-Bet oral lyophilisate Active Ingredients Allergen extract of pollen from white birch
Medicine Name Jext 150mcg Active Ingredients Adrenaline tartrate
Medicine Name Jext 300mcg Active Ingredients Adrenaline tartrate
1 - 0 of 9 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 15 June 2020 SmPC

Reasons for updating

  • Change to section 6.3 - Shelf life

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 19 December 2018 PIL

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 19 December 2018 SmPC

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 5.2 - Pharmacokinetic properties

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 29 June 2018 SmPC

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 6.6 - Special precautions for disposal and other handling

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Section 4.4 updated to include immobilisation of the leg to reduce the risk of laceration

Section 4.5 updated to include thyroid hormones, theophylline, oxytocin, parasympatholytics, diphenhydramine, chlorpheniramine, levodopa and alcohol

Section 6.6 updated to include new diagrams

Updated on 29 June 2018 PIL

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 3 - how to take/use

Updated on 22 November 2016 SmPC

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 6.6 - Special precautions for disposal and other handling

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Changes to 4.4 for patients with a thick sub-cutaneous fat layer
Changes to 6.6  educational materials

Updated on 22 November 2016 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 22 November 2016 PIL

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 6.6 - Special precautions for disposal and other handling

Free text change information supplied by the pharmaceutical company

Changes to 4.4 for patients with a thick sub-cutaneous fat layer
Changes to 6.6  educational materials

Updated on 9 November 2016 PIL

Reasons for updating

  • New PIL for new product

Updated on 23 November 2015 PIL

Reasons for updating

  • Change to section 6.4 - Special precautions for storage

Free text change information supplied by the pharmaceutical company

Change in storage conditions to keep below 25°C

Updated on 23 November 2015 SmPC

Reasons for updating

  • Change to section 6.4 - Special precautions for storage

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Change in storage conditions to keep below 25°C

Updated on 6 March 2014 SmPC

Reasons for updating

  • Change to section 6.3 - Shelf life

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Shelf life changed to 18 months from manufacture

Updated on 6 March 2014 PIL

Reasons for updating

  • Change to section 6.3 - Shelf life

Free text change information supplied by the pharmaceutical company

Shelf life changed to 18 months from manufacture

Updated on 16 May 2013 PIL

Reasons for updating

  • Change to section 6.6 - Special precautions for disposal and other handling

Free text change information supplied by the pharmaceutical company

In section 6.6, 'Dial 999, ask for ambulance, state anaphylaxis' has been added to step 5 of the administration diagram

Updated on 16 May 2013 SmPC

Reasons for updating

  • Change to section 6.6 - Special precautions for disposal and other handling

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

In section 6.6, 'Dial 999, ask for ambulance, state anaphylaxis' has been added to step 5 of the administration diagram

Updated on 4 January 2012 SmPC

Reasons for updating

  • New SPC for new product

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

None provided

Updated on 4 January 2012 PIL

Reasons for updating

  • New SPC for new product

Free text change information supplied by the pharmaceutical company

None provided